September 2026

Summary of Clinical Impact Agent Identified Active Ingredient Borrelia burgdorferi and/or garinii: Spirochete Borrelia burgdorferi and/or garinii: Stationary Borrelia burgdorferi and/or garinii: Biofilm Bartonella henselae: Active Bartonella henselae: Stationary Bartonella henselae: Biofilm Babesia Species Allicin (garlic) Diallyl Disulfide (DADS) 2 16,24 Alchornea cordifolia Ellagic acid 13 Artemisia annua (Sweet wormwood) Artemisinin 13 1,7,11 1,13 Berberis vulgaris Berberine 5 19,25,21 Betula

The Lyme Literate Author of 15 Books Quoting Shor Sweet wormwood, Chinese wormwood, and Qing Hao, Artemisia annua has been used for over 2000 years with particular attention to treating malaria. Active components of Artemisia annua include artemisinin, artesunate, and artemether, all of which are potent antimalarial drugs. The active ingredient artemisinin has been shown to have in vitro activity

A Top Lyme-Literate Practitioner With 30+ Years of Experience Looks at Venlafaxine (Effexor) and OCD Venlafaxine may be effective for OCD, including in patients who do not respond to SSRIs, with response rates ranging from 40% to 70% in clinical studies. Clinical Evidence Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), has been studied as an alternative to SSRIs for OCD. In

This is a book on Natural Medicine. But here are Synthetic Options Top and Emerging Synthetic Anti-Inflammatory Drugs Small-molecule pharmaceuticals; biologic monoclonal antibodies are excluded. I have separated established agents from newer/emerging targeted molecules. Ranking is approximate because potency and usefulness depend heavily on the disease. JAK/TYK2, PDE4, BTK, NLRP3 and RIPK1 inhibition are among the most important areas of